EVOKE PHARMA

evoke-pharma-logo

Evoke Pharma, Inc. is a privately held specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases. The Company was established by experienced specialty pharmaceutical executives with a successful track record of acquiring, developing, registering, and marketing pharmaceutical products in the US. Evoke has concentrated on the gastroenterology field due to the significant unmet medical needs, the opportunity to improve known products and its focused physician base... . Despite the relatively high number of patients suffering from gastrointestinal diseases and disorders, there are only about 12,000 gastroenterologists in the U.S. These physicians conduct over 31 million patient visits and write almost 40 million prescriptions each year valued at $4.8 billion. Also, GI diseases may limit or alter the effectiveness of traditional oral therapies due to the disease for which the product is intended to treat. By developing enhanced versions of currently approved drug products, through novel delivery formats or formulations, Evoke intends to provide patients additional treatment options. Evoke's lead product candidate, EVK-001, is in late stage clinical testing. The company has exclusive rights to a novel formulation and delivery of a currently marketed GI product. The product is intended for the treatment of diabetic gastroparesis. Evoke has advanced its product development activities by leveraging several corporate relationships with many external clinical, CMC, and regulatory experts. Evoke plans to continue this strategy of developing acquired products in partnership with various global organizations depending upon new acquisitions and appropriate asset investment.

#SimilarOrganizations #People #Financial #Website #More

EVOKE PHARMA

Industry:
Biotechnology Health Care Therapeutics

Founded:
2007-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.evokepharma.com

Total Employee:
11+

Status:
Active

Contact:
7604871255

Email Addresses:
[email protected]

Total Funding:
28.19 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Wordpress Plugins Nginx Sitelinks Search Box


Similar Organizations

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

auration-biotech-logo

Auration Biotech

Auration Biotech develops therapeutics for the treatment of ear, nose, and throat diseases.

enobia-pharma-logo

Enobia Pharma

Enobia Pharma develops therapies for the treatment of serious genetic bone disorders.

kodiak-sciences-logo

Kodiak Sciences

Kodiak is designing and developing novel therapies for the treatment of retinal disease.

meritage-pharma-logo

Meritage Pharma

Meritage Pharma develops prescription products for the treatment of gastrointestinal and atopic diseases.

milestone-pharmaceuticals-logo

Milestone Pharmaceuticals

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

nephrx-corporation-logo

NephRx Corporation

NephRx Corporation develops therapeutic products for acute kidney failure, renal disorders, and diseases of the gastrointestinal tract.

targeted-medical-pharma-logo

Targeted Medical Pharma

Targeted Medical Pharma develops therapeutic systems for the nutritional management of chronic diseases.

tioga-pharmaceuticals-logo

Tioga Pharmaceuticals

Tioga Pharmaceuticals develops therapies for the treatment of gastrointestinal diseases.


Current Advisors List

ken-widder_image

Ken Widder Board Member @ Evoke Pharma
Board_member

vickie-reed_image

Vickie Reed Board Member @ Evoke Pharma
Board_member
2021-05-01

todd-c-brady_image

Todd C. Brady Board Member @ Evoke Pharma
Board_member

Current Employees Featured

marilyn-r-carlson_image

Marilyn R. Carlson
Marilyn R. Carlson CMO @ Evoke Pharma
CMO
2013-12-01

dave-gonyer_image

Dave Gonyer
Dave Gonyer Co-Founder, CEO @ Evoke Pharma
Co-Founder, CEO
2007-03-01

not_available_image

Matthew J. Dโ€™Onofrio
Matthew J. Dโ€™Onofrio Founder & Chief Business Officer @ Evoke Pharma
Founder & Chief Business Officer
2007-01-01

Founder


dave-gonyer_image

Dave Gonyer

not_available_image

Matthew J. Dโ€™Onofrio

Stock Details


Company's stock symbol is NASDAQ:EVOK

Investors List

square-1-bank_image

Square 1 Bank

Square 1 Bank investment in Post-IPO Debt - Evoke Pharma

domain-associates_image

Domain Associates

Domain Associates investment in Series A - Evoke Pharma

latterell-venture-partners_image

Latterell Venture Partners

Latterell Venture Partners investment in Series A - Evoke Pharma

Official Site Inspections

http://www.evokepharma.com Semrush global rank: 4.93 M Semrush visits lastest month: 1.75 K

  • Host name: 21.28.196.104.bc.googleusercontent.com
  • IP address: 104.196.28.21
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Evoke Pharma"

Evoke Pharma

Leadership evokepharma 2024-06-05T18:15:06+00:00. OUR LEADERSHIP. ... Prior to joining Evoke, in 2012 Dr. Carlson helped found Agility Clinical, Inc., a contract research organization โ€ฆSee details»

Evoke Pharma - businessabc

Oct 19, 2024 Evoke Pharma, Inc. was founded in 2007 by entrepreneur and investor Keith P. Aldredge. The company began in his basement and has grown to a dynamic publicly-traded โ€ฆSee details»

Corporate Governance - Evoke Pharma

Corporate Governance evokepharma 2024-01-18T18:08:00+00:00. CORPORATE GOVERNANCE. Audit Committee Charter; Compensation Committee Charter; Nominating & โ€ฆSee details»

Evoke Pharma - Crunchbase Company Profile & Funding

Evoke Pharma, Inc. is a privately held specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases. The Company was established by experienced specialty โ€ฆSee details»

Evoke Pharma Company Profile | Management and Employees List โ€ฆ

Www.evokepharma.com . Evoke Pharma Profile and History. Evoke is a specialty pharmaceutical company focused primarily on the commercialization and development of drugs to treat GI โ€ฆSee details»

Company Evoke Pharma, Inc. BOERSE MUENCHEN

Dec 31, 2006 Evoke Pharma, Inc. 420 Stevens Avenue Suite 370. 92075-2074, Solana Beach +858 345 1494. http://www.evokepharma.comSee details»

Evoke Pharma, Inc. (EVOK) Company Profile & Overview - Stock โ€ฆ

3 days ago 420 Stevens Avenue, Suite 230 Solana Beach, California 92075 United StatesSee details»

Evoke Pharma, Inc. (EVOK) Company Profile & Facts - Yahoo Finance

See the company profile for Evoke Pharma, Inc. (EVOK) including business summary, industry/sector information, number of employees, business summary, corporate governance, โ€ฆSee details»

Company Evoke Pharma, Inc. - MarketScreener.com

Dec 31, 2006 Evoke Pharma, Inc. 420 Stevens Avenue Suite 370. 92075-2074, Solana Beach +858 345 1494. http://www.evokepharma.comSee details»

Evoke Pharma - Overview, News & Similar companies - ZoomInfo

Feb 13, 2024 View Evoke Pharma (www.evokepharma.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees โ€ฆSee details»

Evoke Pharma Company Profile 2024: Stock Performance

Evoke Pharma General Information Description. Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, โ€ฆSee details»

Board of Directors - Evoke Pharma

Kenneth J. Widder, M.D. Kenneth J. Widder, M.D., has served as a member of our board of directors since June 2007.Dr. Widder has 36 years of experience working with biomedical โ€ฆSee details»

Evoke Pharma Company Overview, Contact Details & Competitors โ€ฆ

Feb 9, 2024 [email protected]: [email protected]: 5%. [email protected]: [email protected]: 5%. See more formats. Frequently โ€ฆSee details»

Evoke Pharma, Inc. - Dun & Bradstreet

Company Description: Who says nasal spray is just for sinus problems? Evoke Pharma is developing a nasal spray to treat gastrointestinal problems in women who also suffer from โ€ฆSee details»

Evoke Pharma - Craft

Evoke Pharma has 3 employees at their 1 location and $5.18 m in annual revenue in FY 2023. See insights on Evoke Pharma including office locations, competitors, revenue, financials, โ€ฆSee details»

How Does Evoke Pharma Work? โ€“ CBM

4 days ago Website: evokepharma.com; Focus: Developing therapeutics for gastrointestinal diseases; With a team of dedicated professionals and experts in the field of gastroenterology, โ€ฆSee details»

Evoke Pharma Highlights GIMOTI as a Leading Solution for โ€ฆ

3 days ago Gastroparesis is a debilitating GI disorder wherein delayed stomach emptying, causes significant nausea, vomiting, early satiety, and abdominal pain often leading to โ€ฆSee details»

Contact Us - Evoke Pharma

Contact Us evokepharma 2024-04-02T17:58:25+00:00. CONTACT US. Corporate Headquarters: 420 Stevens Avenue, Suite 230 Solana Beach, CA 92075 (858) 345-1494. Medical โ€ฆSee details»

Evoke Pharma Highlights GIMOTI as a Leading Solution for

3 days ago FDA posts update as mechanism to obtain unapproved Domperidone expected to lose supply in early 2025. Gimoti remains only approved drug shown to reduce โ€ฆSee details»

Evoke Pharma Addresses FDA Update on Domperidone Supply โ€ฆ

3 days ago Evoke Pharma, Inc. announces its commitment to addressing the needs of patients with gastroparesis following the FDA's update indicating that the supply of unapproved โ€ฆSee details»

linkstock.net © 2022. All rights reserved